Tag: Dr. Andy Morgenstern

This SEO-optimized clinical briefing is designed for the optometric community. It synthesizes the AOA Evidence-Based Optometry (EBO) Committee June 2025 clinical report with the professional insights of Dr. Andrew Morgenstern, Director of the AOA Clinical Resources Group, regarding the management of patients on GLP-1 receptor agonists.